06.01.2013 Views

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(A61K) II.1(1)<br />

A61K <strong>31</strong>/47 → (51) C07D 215/14<br />

A61K <strong>31</strong>/4709 → (51) C07D 401/12<br />

A61K <strong>31</strong>/473 → (51) C07D 221/16<br />

(51) A61K <strong>31</strong>/495 (11) 1 893 207 B1<br />

A61K <strong>31</strong>/496 A61K <strong>31</strong>/5375<br />

A61K <strong>31</strong>/5377 A61P 17/00<br />

C07D 241/04<br />

(25) De (26) De<br />

(21) 06753700.1 (22) 18.05.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 05.03.2008<br />

(86) EP 2006/004709 18.05.2006<br />

(87) WO 2006/133784 2006/51 21.12.2006<br />

(30) 16.06.2005 DE 102005027865<br />

22.12.2005 DE 102005061657<br />

(54) • VERWENDUNG VON SUBSTITUIERTEN<br />

PIPERAZIN- UND MORPHOLINDERIVATEN<br />

• USE OF SUBSTITUTED PIPERAZINE<br />

DERIVATIVES AND MORPHOLINE DERI-<br />

VATIVES<br />

• UTILISATION DE DERIVES DE PIPERAZINE<br />

ET DE MORPHOLINE SUBSTITUES<br />

(73) Merck <strong>Patent</strong> GmbH, Frankfurter Strasse<br />

250, 64293 Darmstadt, DE<br />

(72) MUJICA-FERNAUD, Teresa, 64289 Darmstadt,<br />

DE<br />

BUCHHOLZ, Herwig, 60599 Frankfurt, DE<br />

A61K <strong>31</strong>/496 → (51) A61K <strong>31</strong>/495<br />

A61K <strong>31</strong>/497 → (51) C07D 401/14<br />

(51) A61K <strong>31</strong>/505 (11) 2 117 552 B1<br />

A61P 29/00<br />

(25) En (26) En<br />

(21) 08716828.2 (22) 13.02.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 18.11.2009<br />

(86) EP 2008/0517<strong>31</strong> 13.02.2008<br />

(87) WO 2008/098957 2008/34 21.08.2008<br />

(30) 14.02.2007 EP 07102410<br />

(54) • VERWENDUNG VON KONDENSIERTEN<br />

PYRIMIDINDERIVATEN ZUR BEHAND-<br />

LUNG VON AUTOIMMUN- UND ENTZÜN-<br />

DUNGSERKRANKUNGEN<br />

• USE OF CONDENSED PYRIMIDINE DERI-<br />

VATIVES FOR THE TREATMENT OF<br />

AUTOIMMUNE AND INFLAMMATORY<br />

DISEASES<br />

• UTILISATION DE DÉRIVÉS CONDENSÉS<br />

DE PYRIMIDINE POUR LE TRAITEMENT<br />

DES MALADIES AUTO-IMMUNES ET<br />

INFLAMMATOIRES<br />

(73) Stoicescu, Dan, ch. de la Dullive 3, 1195<br />

Dully, CH<br />

(72) Stoicescu, Dan, 1195 Dully, CH<br />

(74) Killin, Stephen James, et al, Venner Shipley<br />

LLP 20 Little Britain, London EC1A 7DH, GB<br />

A61K <strong>31</strong>/505 → (51) C07D 239/48<br />

A61K <strong>31</strong>/505 → (51) C07D 473/16<br />

A61K <strong>31</strong>/506 → (51) C07D 239/48<br />

A61K <strong>31</strong>/513 → (51) C07D 239/557<br />

A61K <strong>31</strong>/513 → (51) C07D 401/04<br />

A61K <strong>31</strong>/519 → (51) C07D 401/12<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

A61K <strong>31</strong>/519 → (51) C07D 495/04<br />

A61K <strong>31</strong>/52 → (51) C07D 473/16<br />

A61K <strong>31</strong>/522 → (51) C07D 473/16<br />

(51) A61K <strong>31</strong>/5365 (11) 1 212 055 B1<br />

A61K <strong>31</strong>/424 A61P 25/22<br />

A61P 25/24 A61P 25/28<br />

A61P 25/16<br />

(25) En (26) En<br />

(21) 00959244.5 (22) 16.08.2000<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 12.06.2002<br />

(86) US 2000/022450 16.08.2000<br />

(87) WO 2001/012184 2001/08 22.02.2001<br />

(30) 16.08.1999 US 149115 P<br />

17.12.1999 US 172452 P<br />

18.01.2000 US 176570 P<br />

04.04.2000 US 194534 P<br />

(54) • Beta-lactam Verbindung enthaltende neurotherapeutische<br />

Zusammensetzung<br />

• Neurotherapeutic composition comprising<br />

a beta-lactam compound<br />

• Composition neurothérapeutique comprenant<br />

un composé beta-lactam<br />

(73) Revaax Pharmaceuticals LLC, P.O. Box<br />

22476, Indianapolis, IN 46222-0476, US<br />

(72) KOPPEL, Gary, A., Indianapolis, IN 46260,<br />

US<br />

(74) von Kreisler Selting Werner, Deichmannhaus<br />

am Dom Bahnhofsvorplatz 1, 50667 Köln,<br />

DE<br />

(60) 10181885.4 / 2 305 251<br />

A61K <strong>31</strong>/5375 → (51) A61K <strong>31</strong>/495<br />

A61K <strong>31</strong>/5377 → (51) A61K <strong>31</strong>/495<br />

A61K <strong>31</strong>/54 → (51) C07D 285/18<br />

A61K <strong>31</strong>/541 → (51) C07D 285/18<br />

A61K <strong>31</strong>/551 → (51) C07D 471/08<br />

(51) A61K <strong>31</strong>/5575 (11) 1 878 429 B1<br />

A61K 9/06 A61K 9/70<br />

A61K 47/06 A61K 47/10<br />

A61K 47/12 A61K 47/14<br />

A61K 47/18 A61K 47/32<br />

A61K 47/34 A61K 47/44<br />

A61P 19/08 A61P 43/00<br />

(25) Ja (26) En<br />

(21) 06745734.1 (22) 27.04.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 16.01.2008<br />

(86) JP 2006/308806 27.04.2006<br />

(87) WO 2006/118173 2006/45 09.11.2006<br />

(30) 28.04.2005 JP 2005130688<br />

(54) • PRÄPARAT ZUR TRANSDERMALEN<br />

ABSORPTION<br />

• TRENADERMAL ABSORPTION PREPAR-<br />

ATION<br />

• PRÉPARATION POUR ABSORPTION<br />

TRANSDERMALE<br />

(73) ONO PHARMACEUTICAL CO., LTD., 1-5,<br />

Doshomachi 2-chome Chuo-ku, Osaka-shi<br />

541-8526, JP<br />

(72) NISHIURA, Akio, ONO PHARMACEUTICAL<br />

CO., LTD., Mishima-gun, Osaka 618-8585,<br />

JP<br />

SUGIHARA, Hikaru, ONO PHARMACEUTICAL<br />

CO., LTD., Mishima-gun, Osaka 618-8585,<br />

JP<br />

728<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>31</strong>/<strong>2011</strong>) 03.08.<strong>2011</strong><br />

ARAI, Harumi, ONO PHARMACEUTICAL CO.,<br />

LTD., Mishima-gun, Osaka 618-8585, JP<br />

KANAJI, Toshiya, ONO PHARMACEUTICAL<br />

CO., LTD., Mishima-gun, Osaka 618-8585,<br />

JP<br />

(74) McCluskie, Gail Wilson, et al, J.A. Kemp &<br />

Co. 14 South Square Gray's Inn, London<br />

WC1R 5JJ, GB<br />

(51) A61K <strong>31</strong>/57 (11) 1 758 586 B1<br />

A61K <strong>31</strong>/593 A61K 47/44<br />

A61K 47/10 A61K 9/12<br />

A61P 17/00 A61P 17/06<br />

(25) En (26) En<br />

(21) 05770876.0 (22) 15.06.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

LV<br />

(43) 07.03.2007<br />

(86) EP 2005/007972 15.06.2005<br />

(87) WO 2005/123090 2005/52 29.12.2005<br />

(30) 17.06.2004 FR 0406611<br />

28.09.2004 US 950650 P<br />

(54) • ZUSAMMENSETZUNG IN SPRAYFORM<br />

MIT EINER KOMBINATION AUS EINEM<br />

KORTIKOID UND EINEM VITAMIN-D-<br />

DERIVAT IN EINER ÖLPHASE<br />

• COMPOSITION IN SPRAY FORM COM-<br />

PRISING A COMBINATION OF A CORTI-<br />

COID AND A VITAMIN D DERIVATIVE IN<br />

AN OILY PHASE<br />

• COMPOSITION SOUS FORME DE SPRAY<br />

COMPRENANT UNE COMBINAISON D'UN<br />

CORTICOIDE ET D'UN DERIVE DE LA<br />

VITAMINE D DANS UNE PHASE HUILEUSE<br />

(73) Galderma S.A., Zugerstrasse 8, 6330 Cham,<br />

CH<br />

(72) WILLCOX, Nathalie, F-06460 Saint Vallier de<br />

Thiey, FR<br />

ORSONI, Sandrine, F-06210 Mandelieu, FR<br />

FREDON, Laurent Chemin du Camouyer, F-<br />

06330 Roquefort les Pins, FR<br />

(74) Allab, Myriam, L'Oréal D.I.P.I. 25-29 Quai<br />

Aulagnier, 92600 Asnières, FR<br />

A61K <strong>31</strong>/58 → (51) A61K 9/00<br />

A61K <strong>31</strong>/593 → (51) A61K <strong>31</strong>/57<br />

A61K <strong>31</strong>/7016 → (51) C07K 16/30<br />

A61K <strong>31</strong>/7105 → (51) C12N 15/11<br />

(51) A61K 33/06 (11) 1 846 010 B1<br />

A61K 8/26 A61K 8/891<br />

A61P 17/00<br />

(25) En (26) En<br />

(21) 05811402.6 (22) 25.11.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 24.10.2007<br />

(86) JP 2005/022139 25.11.2005<br />

(87) WO 2006/067945 2006/26 29.06.2006<br />

(30) 22.12.2004 JP 2004371895<br />

(54) • TOPISCHES HAUTMITTEL MIT MODIFI-<br />

ZIERTEM TON ZUR VERHINDERUNG VON<br />

ENTZÜNDUNGEN<br />

• EXTERNAL SKIN AGENT COMPRISING<br />

MODIFIED CLAY FOR PREVENTING<br />

INFLAMMATION<br />

• AGENT CUTANE EXTERNE COMPRENANT<br />

DE L'ARGILE MODIFIEE UTILE EN PRE-<br />

VENTION DE L'INFLAMMATION<br />

(73) Pola Chemical Industries Inc., 6-48, Yayoicho,<br />

Suruga-ku, Shizuoka-shi, Shizuoka 420-<br />

0914, JP

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!